(Q54535863)

English

Ambulatory prazosin treatment of chronic congestive heart failure: Development of late tolerance reversible by higher dosage and interrupted substitution therapy

scientific article published on May 1, 1981

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/7223594

Ambulatory prazosin treatment of chronic congestive heart failure: Development of late tolerance reversible by higher dosage and interrupted substitution therapy (English)

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

congestive heart failure

1 reference

based on heuristic

inferred from title

Cardiology and cardiovascular medicine

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

author name string

N. A. Awan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7223594

8 March 2024

G. Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7223594

8 March 2024

A. N. DeMaria

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7223594

8 March 2024

D. T. Mason

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7223594

8 March 2024

language of work or name

0 references

publication date

1 May 1981

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/7223594

full work available at URL

https://api.elsevier.com/content/article/PII:0002870381902192?httpAccept=text/xml

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

https://api.elsevier.com/content/article/PII:0002870381902192?httpAccept=text/plain

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/7223594

101

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/7223594

5

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/7223594

541-547

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/7223594

Effects of prazosin on forearm resistance and capacitance vessels

1

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, h

2

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

3

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure

4

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

A long-term clinical trial of prazosin

5

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Experience with prazosin in a clinical setting

6

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Physiologic evaluation of a new antihypertensive agent: prazosin HCl

8

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise

9

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure

11

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure

12

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure

13

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: Prolonged effectiveness of isosorbide dinitrate

14

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Oral hydralazine therapy for chronic refractory heart failure

15

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients

16

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside

18

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation

19

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Cardiovascular and renal adjustments to a hypotensive agent (l'hydrazinophthalazine: Ciba BA-5968: apresoline)

21

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy

22

1 reference

10.1016/0002-8703(81)90219-2

https://api.crossref.org/works/10.1016/0002-8703(81)90219-2

8 March 2024

Identifiers

10.1016/0002-8703(81)90219-2

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/7223594

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 May 2018

http://europepmc.org/abstract/MED/7223594

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54535863&oldid=2096969304"